agree with recommendation
USPSTF Draft Recommendation Eliminates Cervical Cytology-HPV Cotesting for Women Over 30 — Physician’s First Watch
USPSTF Draft Recommendation Eliminates Cervical Cytology-HPV Cotesting for Women Over 30
By Amy Orciari Herman
Women aged 30–65 should undergo cervical cancer screening with either cervical cytology alone every 3 years or high-risk human papillomavirus (HPV) testing alone every 5 years, according to a draft recommendation statement from the U.S. Preventive Services Task Force (grade A recommendation).
This is a change from the USPSTF's 2012 guidelines, which recommended cytology alone every 3 years, or cytology plus HPV testing every 5 years, for women in this age group.
The rest of the task force's recommendations haven't changed. In particular, women aged 21–29 should be screened every 3 years with cytology alone (grade A recommendation). And the following groups should not be screened (all grade D recommendations):
Females younger than 21.
Women older than 65 who've already been screened sufficiently.
Women who've had their cervix removed during hysterectomy.
The recommendations apply to average-risk females (e.g., no history of high-grade precancerous lesions), regardless of their sexual history or HPV vaccination status.